ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

One In 8 Survivors Report Suicidal Thoughts, Attempts

August 25, 2006